Concepedia

Fraser Glickman

FG

Statistics

Publications

5

Citations

302

H-Index

5

Active since

2003

Affiliations

Rockefeller University(Current)

Novartis (Switzerland)

Cornell University

University of Tennessee Health Science Center

Novartis Institutes for BioMedical Research

Fraser Glickman is an author at Rockefeller University specializing in drug discovery, life sciences, and chemokine receptor antagonism.

Publications per year

2003–2012

5

Publications

5

Orally Bioavailable Isothioureas Block Function of the Chemokine Receptor CXCR4 In Vitro and In Vivo

Gebhard Thoma, Markus Streiff, Jiří Kovařík et al. · Journal of Medicinal Chemistry · 2008 · 129 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Simulating Henipavirus Multicycle Replication in a Screening Assay Leads to Identification of a Promising Candidate for Therapy

Matteo Porotto, Gianmarco Orefice, Christine C. Yokoyama et al. · Journal of Virology · 2009 · 91 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Development of a High-Throughput Screening Assay for Inhibitors of Aggrecan Cleavage Using Luminescent Oxygen Channeling (AlphaScreen™)

Jane Peppard, Fraser Glickman, Yang He et al. · SLAS DISCOVERY · 2003 · 47 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

Rapid Screening for Entry Inhibitors of Highly Pathogenic Viruses under Low-Level Biocontainment

Aparna Talekar, Antonello Pessi, Fraser Glickman et al. · PLoS ONE · 2012 · 20 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +16

Special ergolines are highly selective, potent antagonists of the chemokine receptor CXCR3: Discovery, characterization and preliminary SAR of a promising lead

Gebhard Thoma, Rolf Baenteli, Ian Lewis et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 15 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

1–5 of 5